[폐암, 희망은 있다] ⑪ Treatment regardless of cancer type, the only drug for rare NTRK gene fusion lung cancer

[폐암, 희망은 있다] ⑪ Treatment regardless of cancer type, the only drug for rare NTRK gene fusion lung cancer

[인터뷰] Park Se-hoon, Professor, Department of Hematology and Oncology, Samsung Hospital Seoul Professor Park Se-hoon pointed out: “The NTRK gene fusion is only expressed in a very limited number of cases of lung cancer, but since an effective treatment has been developed, active treatment is essential.” Since 1998, for more than 20 years, lung cancer … Read more